Patents by Inventor Neil Feeder

Neil Feeder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CRYSTALLINE PPAR-DELTA AGONIST
    Publication number: 20240002356
    Abstract: Described herein is crystalline sodium (E)-2-(4-((3-(4-fluorophenyl)-3-(4-(3-morpholinoprop-1-yn-1-yl)phenyl)allyl)oxy)-2-methylphenoxy)acetate, uses of such crystalline material in the preparation of pharmaceutical compositions for the treatment of diseases or conditions that would benefit by administration with a PPARS agonist compound.
    Type: Application
    Filed: June 12, 2023
    Publication date: January 4, 2024
    Inventors: Susana DEL RIO GANCEDO, Osama SULEIMAN, Emma SHARP, Cristina BALOGH, Rachael LEE, Julie MACRAE, Neil FEEDER
  • Crystalline PPAR? agonist
    Patent number: 11713301
    Abstract: Described herein is crystalline sodium (E)-2-(4-((3-(4-fluorophenyl)-3-(4-(3-morpholinoprop-1-yn-1-yl)phenyl)allyl)oxy)-2-methylphenoxy)acetate, uses of such crystalline material in the preparation of pharmaceutical compositions for the treatment of diseases or conditions that would benefit by administration with a PPAR? agonist compound.
    Type: Grant
    Filed: January 10, 2022
    Date of Patent: August 1, 2023
    Assignee: RENEO PHARMACEUTICALS, INC.
    Inventors: Susana Del Rio Gancedo, Osama Suleiman, Emma Sharp, Cristina Balogh, Rachael Lee, Julie Macrae, Neil Feeder
  • CRYSTALLINE PPAR-DELTA AGONIST
    Publication number: 20220135532
    Abstract: Described herein is crystalline sodium (E)-2-(4-((3-(4-fluorophenyl)-3-(4-(3-morpholinoprop-1-yn-1-yl)phenyl)allyl)oxy)-2-methylphenoxy)acetate, uses of such crystalline material in the preparation of pharmaceutical compositions for the treatment of diseases or conditions that would benefit by administration with a PPAR? agonist compound.
    Type: Application
    Filed: January 10, 2022
    Publication date: May 5, 2022
    Inventors: Susana DEL RIO GANCEDO, Osama SULEIMAN, Emma SHARP, Cristina BALOGH, Rachael LEE, Julie MACRAE, Neil FEEDER
  • Crystalline PPAR-delta agonist
    Patent number: 11267795
    Abstract: Described herein is crystalline sodium (E)-2-(4-((3-(4-fluorophenyl)-3-(4-(3-morpholinoprop-1-yn-1-yl)phenyl)allyl)oxy)-2-methylphenoxy)acetate, uses of such crystalline material in the preparation of pharmaceutical compositions for the treatment of diseases or conditions that would benefit by administration with a PPAR? agonist compound.
    Type: Grant
    Filed: July 20, 2021
    Date of Patent: March 8, 2022
    Assignee: RENEO PHARMACEUTICALS, INC.
    Inventors: Susana Del Rio Gancedo, Osama Suleiman, Emma Sharp, Cristina Balogh, Rachael Lee, Julie Macrae, Neil Feeder
  • CRYSTALLINE PPAR-DELTA AGONIST
    Publication number: 20220024888
    Abstract: Described herein is crystalline sodium (E)-2-(4-((3-(4-fluorophenyl)-3-(4-(3-morpholinoprop-1-yn-1-yl)phenyl)allyl)oxy)-2-methylphenoxy)acetate, uses of such crystalline material in the preparation of pharmaceutical compositions for the treatment of diseases or conditions that would benefit by administration with a PPAR? agonist compound.
    Type: Application
    Filed: July 20, 2021
    Publication date: January 27, 2022
    Inventors: Susana DEL RIO GANCEDO, Osama SULEIMAN, Emma SHARP, Cristina BALOGH, Rachael LEE, Julie MACRAE, Neil FEEDER
  • SOLID MOLECULAR DISPERSION OF FESOTERODINE HYDROGEN FUMARATE AND POLYMERIC BINDER
    Publication number: 20170281586
    Abstract: The present invention relates to solid molecular dispersion of fesoterodine hydrogen fumarate and a polymeric binder. The invention also relates to an inert core bead or particle which is coated with said solid molecular dispersion and to pharmaceutical formulations comprising such coated beads or particles.
    Type: Application
    Filed: April 12, 2017
    Publication date: October 5, 2017
    Applicant: Pfizer Limited
    Inventors: Roland Bodmeier, Alan Francis Carmody, Mesut Ciper, Anne Therese Gustaaf De Paepe, John Mark Heimlich, Martin Korber, Mathias Walther, Neil Feeder
  • Solid molecular dispersion of fesoterodine hydrogen fumarate and polymeric binder
    Patent number: 9668998
    Abstract: The present invention relates to a solid molecular dispersion of from 3:97 to 12:88 weight % ratio of fesoterodine hydrogen fumarate and a polymeric binder selected from the group consisting of an alkyl hydroxyalkylcellulose ether, a hydroxyalkylcellulose ether, an ester of either thereof, and a mixture of any two or more thereof.
    Type: Grant
    Filed: January 17, 2012
    Date of Patent: June 6, 2017
    Assignee: Pfizer Limited
    Inventors: Roland Bodmeier, Alan Francis Carmody, Mesut Ciper, Anne Therese Gustaaf De Paepe, John Mark Heimlich, Martin Korber, Mathias Walther, Neil Feeder
  • Solid Molecular Dispersion
    Publication number: 20130287847
    Abstract: The present invention relates to a solid molecular dispersion of fesoterodine hydrogen fumarate and a polymeric binder. The invention also relates to an inert core bead or particle which is coated with said solid molecular dispersion and to pharmaceutical formulations comprising such coated beads or particles.
    Type: Application
    Filed: January 17, 2012
    Publication date: October 31, 2013
    Inventors: Roland Bodmeier, Alan Francis Carmody, Mesut Ciper, Anne Therese Gustaaf De Paepe, John Mark Heimlich, Martin Korber, Mathias Walther, Neil Feeder